Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The advantage of lower doses is dramatically reduced side effect burden
For patients with high triglycerides as a primary concern, this dual mechanism makes tirzepatide a particularly relevant option to discuss with a provider
Tirzepatide is a dual agonist that activates both GIP and GLP-1 receptors, which is thought to explain its larger average weight loss in clinical trials
In clinical studies, it was shown to lower the risk of heart attack, stroke, or death due to heart problems in certain people by 26%
US$ 27.34
US$ 20.85
US$ 22.02
US$ 21.74
